MedTrace Logo

Treatment of NAFLD With Two Different Diets

NCT03118310 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2020-09-02

No results posted yet for this study

Summary

The impact of popular diets on liver-related health is unclear. In this randomized, controlled trial, patients with NAFLD will be randomized to one of two popular diets or a placebo diet.

Conditions

  • NAFLD

Interventions

BEHAVIORAL

5:2 diet

Dietary intervention according to 5:2 diet during three months.

BEHAVIORAL

LCHF

Dietary intervention according to LCHF diet during three months.

BEHAVIORAL

Placebo diet

Placebo diet: normal dietary advice

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Hannes Hagström, MD, PhD · Karolinska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03118310 on ClinicalTrials.gov